Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.

Creative Commons License

Majidova N., Seyyar M., Bayraktar D. I., Dinç G., İsgandarov E., Huseynov J., ...Daha Fazla

Biomolecules & biomedicine, 2024 (Hakemli Dergi) identifier